3billion, Inc. (KOSDAQ:394800)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,660.00
+90.00 (1.37%)
At close: Aug 4, 2025, 3:30 PM KST
1.37%
Market Cap211.27B
Revenue (ttm)6.85B
Net Income (ttm)-6.51B
Shares Out31.72M
EPS (ttm)-219.90
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume141,645
Average Volume332,479
Open6,500.00
Previous Close6,570.00
Day's Range6,480.00 - 6,730.00
52-Week Range3,025.00 - 8,280.00
Betan/a
RSI42.24
Earnings Daten/a

About United States Steel

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 394800
Full Company Profile

Financial Performance

In 2024, 3billion's revenue was 5.77 billion, an increase of 111.41% compared to the previous year's 2.73 billion. Losses were -6.57 billion, 29.1% more than in 2023.

Financial Statements

News

There is no news available yet.